» Articles » PMID: 12601208

Coarse Nodular US Pattern in Hepatic Cirrhosis: Risk for Hepatocellular Carcinoma

Overview
Journal Radiology
Specialty Radiology
Date 2003 Feb 26
PMID 12601208
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine the prevalence of the coarse nodular ultrasonographic (US) pattern and its prognostic importance in terms of hepatocellular carcinoma (HCC) risk in hepatic cirrhosis caused by hepatitis B virus (HBV); HBV with hepatitis D virus (HDV), formerly known as hepatitis delta virus; hepatitis C virus (HCV); and alcoholic cirrhosis (ALC) or primary biliary disease (primary biliary cirrhosis [PBC]).

Materials And Methods: Four hundred two cases of hepatic cirrhosis caused by HBV (94 patients), HDV (100 patients), HCV (100 patients), ALC (63 patients), or PBC (45 patients) were retrospectively reviewed to identify the US pattern present at diagnosis and its possible association with the cause of the disease and subsequent development of HCC during a mean follow-up of 43.9 months +/- 29.9 (SD). Data were analyzed with the chi2, Fisher exact, and log-rank tests and with the Kaplan-Meier method (all two-tailed).

Results: The coarse nodular pattern was found in a significantly higher percentage of patients with HDV-related cirrhosis (51%) compared with those with HBV (9%), HCV (9%), ALC (11%), or PBC (9%) (P <.001). This pattern was associated with a significantly increased risk for HCC in patients with cirrhosis and HBV-, HCV-, and ALC-related disease but not in those with HDV-related disease and PBC.

Conclusion: The coarse nodular pattern is more often seen in patients with HDV-related cirrhosis, and, in this setting (in contrast to HBV-, HCV-, and ALC-related cirrhosis, as well as in PBC), it does not represent an added risk factor for HCC.

Citing Articles

Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver disease.

Dana J, Venkatasamy A, Saviano A, Lupberger J, Hoshida Y, Vilgrain V Hepatol Int. 2022; 16(3):509-522.

PMID: 35138551 PMC: 9177703. DOI: 10.1007/s12072-022-10303-0.


Non-enhanced Magnetic Resonance Imaging Compared to Ultrasound as a Surveillance Tool for Hepatocellular Carcinoma. Not all that glitters is gold: the ultrasound hepatologist's point of view.

Giorgio A, De Luca M, Gatti P, Giorgio V J Ultrasound. 2021; 25(1):129-131.

PMID: 33389594 PMC: 8964864. DOI: 10.1007/s40477-020-00543-x.


Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.

Natarajan Y, Tansel A, Patel P, Emologu K, Shukla R, Qureshi Z Dig Dis Sci. 2020; 66(7):2439-2451.

PMID: 32743773 DOI: 10.1007/s10620-020-06498-7.


Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns.

Soresi M, Terranova A, Licata A, Serruto A, Montalto G, Brancatelli G Biomed Res Int. 2017; 2017:4932759.

PMID: 28638828 PMC: 5468575. DOI: 10.1155/2017/4932759.


Prediction of development of hepatocellular carcinoma using a new scoring system involving virtual touch quantification in patients with chronic liver diseases.

Aoki T, Iijima H, Tada T, Kumada T, Nishimura T, Nakano C J Gastroenterol. 2016; 52(1):104-112.

PMID: 27306373 DOI: 10.1007/s00535-016-1228-7.